Bosh sahifa4AB • FRA
add
AbbVie
Yopilish kursi
194,60 €
Kunlik diapazon
192,20 € - 195,40 €
Yillik diapazon
147,00 € - 209,50 €
Bozor kapitalizatsiyasi
404,70 mlrd USD
Oʻrtacha hajm
291,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 15,42 mlrd | 6,65% |
Joriy xarajat | 5,29 mlrd | 0,53% |
Sof foyda | 938,00 mln | -31,53% |
Sof foyda marjasi | 6,08 | -35,80% |
Har bir ulushga tushum | 2,97 | 12,08% |
EBITDA | 7,84 mlrd | 9,93% |
Amaldagi soliq stavkasi | 39,45% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 6,47 mlrd | -50,85% |
Jami aktivlari | 137,18 mlrd | -3,35% |
Jami passivlari | 137,32 mlrd | 1,63% |
Umumiy kapital | -138,00 mln | — |
Tarqatilgan aksiyalar | 1,77 mlrd | — |
Narxi/balansdagi bahosi | -1,95 ming | — |
Aktivlardan daromad | 10,59% | — |
Kapitaldan daromad | 20,39% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 938,00 mln | -31,53% |
Operatsiyalardan naqd pul | 5,15 mlrd | 126,90% |
Sarmoyadan naqd pul | -1,18 mlrd | -7,17% |
Moliyadan naqd pul | -2,71 mlrd | 55,55% |
Naqd pulning sof oʻzgarishi | 1,29 mlrd | 126,17% |
Boʻsh pul | 6,02 mlrd | 105,93% |
Haqida
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000.
The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Tashkil etilgan
10-apr, 2012
Sayt
Xodimlar soni
55 000
